Adar1 Capital Management, LLC Context Therapeutics Inc. Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
A detailed history of Adar1 Capital Management, LLC transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 645,161 shares of CNTX stock, worth $1.35 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
645,161
Previous 205,934
213.29%
Holding current value
$1.35 Million
Previous $284 Million
355.17%
% of portfolio
0.24%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding CNTX
# of Institutions
37Shares Held
57.2MCall Options Held
0Put Options Held
0-
Great Point Partners LLC Greenwich, CT7.42MShares$15.5 Million3.93% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$15.5 Million0.49% of portfolio
-
Nextech Invest Ag7.42MShares$15.5 Million2.8% of portfolio
-
Avidity Partners Management LP Dallas, TX7.42MShares$15.5 Million0.73% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.16MShares$10.8 Million4.29% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $33.4M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...